Voyager Therapeutics, Inc.

VYGR ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $252.3M

Liabilities Breakdown FY2025

Total Liabilities: $56.2M